<?xml version="1.0" encoding="UTF-8"?>
<p>Reverse genetics is a useful tool for the development of novel vaccines and antiviral drugs. For example, escape mutants can be investigated by reverse genetic technique, providing clues to the binding site of a target protein and mechanism of action for an antiviral [
 <xref rid="B20-viruses-11-00665" ref-type="bibr">20</xref>]. In addition, replication competent recombinant reporter IAVs that express fluorescent proteins or luciferases provide a simple and robust approach for antiviral studies [
 <xref rid="B25-viruses-11-00665" ref-type="bibr">25</xref>,
 <xref rid="B26-viruses-11-00665" ref-type="bibr">26</xref>,
 <xref rid="B27-viruses-11-00665" ref-type="bibr">27</xref>,
 <xref rid="B28-viruses-11-00665" ref-type="bibr">28</xref>]. However, most currently available reporter IAVs are constructed with either A/Puerto Rico/8/1934 (H1N1; PR8) or A/WSN/1933 (H1N1) as the backbone (reviewed in Reference [
 <xref rid="B29-viruses-11-00665" ref-type="bibr">29</xref>]). For other subtypes, to our knowledge, only reporter IAVs of H5N1 and H7N9 have been generated [
 <xref rid="B30-viruses-11-00665" ref-type="bibr">30</xref>,
 <xref rid="B31-viruses-11-00665" ref-type="bibr">31</xref>]. In spite of their clinical importance, reporter IAVs of subtype H3N2 have not been reported. Here we report the successful generation of a reporter reassortant influenza A subtype H3N2 virus carrying the 
 <italic>Gaussia</italic> luciferase (Gluc) gene.
</p>
